Next generation CD44v6-specific CAR-NK cells for the treatment of solid tumors

被引：0

作者：

Pecher, Gabriele

Franzen, Alexander Sebastian

Boulifa, Abdelhadi

Radecke, Clarissa

Stintzing, Sebastian

Raftery, Martin

机构：

[1] Charite, Berlin, Germany

[2] Charite Univ Med Berlin, Berlin, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14518

引用

页数：1

共 50 条

[31] Specificity and efficacy of second generation CAR T-cells against CD44v6 antigen in primary HNSCC cells
Haist, C.
Schulte, E.
Bister, A.
Scheckenbach, K.
Hanenberg, H.
Wiek, C.
HUMAN GENE THERAPY, 2019, 30 (11) : A70 - A70
[32] Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
Vermeulen, Jeroen F.
van Brussel, Aram S. A.
Adams, Arthur
Mali, Willem P. Th. M.
van der Wall, Elsken
van Diest, Paul J.
Derksen, Patrick W. B.
MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (03) : 290 - 298
[33] Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
Jeroen F. Vermeulen
Aram S. A. van Brussel
Arthur Adams
Willem P. Th. M. Mali
Elsken van der Wall
Paul J. van Diest
Patrick W. B. Derksen
Molecular Imaging and Biology, 2013, 15 : 290 - 298
[34] CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
Leuci, V.
Casucci, G. M.
Grignani, G.
Rotolo, R.
Rossotti, U.
Vigna, E.
Gammaitoni, L.
Mesiano, G.
Fiorino, E.
Donini, C.
Pisacane, A.
Ambrosio, L. D.
Pignochino, Y.
Aglietta, M.
Bondanza, A.
Sangiolo, D.
ONCOIMMUNOLOGY, 2018, 7 (05):
[35] CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells
Haist, Corinna
Schulte, Elena
Bartels, Nina
Bister, Arthur
Poschinski, Zoe
Ibach, Tabea C.
Geipel, Katja
Wiek, Constanze
Wagenmann, Martin
Monzel, Cornelia
Scheckenbach, Kathrin
Hanenberg, Helmut
ORAL ONCOLOGY, 2021, 116
[36] "Dual Targeting" of CAR-NK Cells against PD-L1 and HER2 enables the specific Elimination of solid Tumors and overcomes "immune escape" through Antigen Loss
Eitler, J.
Freudenberg, K.
Montero, P. Ortiz
Bornhauser, M.
Wels, W. S.
Tonn, T.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 124 - 124
[37] DEVELOPMENT OF AB-201, A NOVEL ALLOGENEIC ANTI-HER2-SPECIFIC CAR-NK CELL THERAPY FOR THE TREATMENT OF HER2+TUMORS
Lim, Hoyong
Medcalf, Amanda
Guerrettaz, Lisa
Choi, Eun Ji
Kim, Hansol
Yang, Bitna
Kim, Eun Ji
Lee, Eun-Sol
Kim, Jeong Min
Kim, Yusun
Min, Bokyung
Paik, Sang-Min
Nam, Hyeong Jin
Han, Seungryel
Somanchi, Srinivas
Helsel, Eugene
Litten, Jason
Flynn, Peter
Raymon, Heather
Hwang, Yu-Kyeong
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A138 - A138
[38] Off-the-Shelf, Multiplexed-Engineered iPSC-Derived CD33 CAR-NK Cells for Treatment of Acute Myeloid Leukemia
Wang, Yiyun
Wang, Linqin
Shao, Mi
He, Xiangjun
Yue, Yanan
Zhou, Yixuan
Yang, Luhan
Huang, He
Hu, Yongxian
BLOOD, 2022, 140 : 12685 - 12685
[39] SENTI-401, AN ALLOGENEIC LOGIC-GATED AND MULTIARMED CAR-NK CELL THERAPY FOR THE TREATMENT OF CEA-EXPRESSING SOLID TUMORS WITH ENHANCED SELECTIVITY AND EFFICACY
Junca, Alba Gonzalez
Frankel, Nicholas
Morvan, Maelig
Roguev, Assen
Hung, Michelle
Gordley, Russell
Palermo, Miguel
Santomaso, Tyler
Chinta, Pearley
Sotelo, Aldo
Gainer, Marcus
Lee, Derrick
Hua, Tony
Banicki, Andrew
Tian, Mengxi
Almudhfar, Niran
Contreras, Atahualpa
Lee, Chen-Ting
Lu, Timothy
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A235 - A235
[40] CAR-T cells, tumor antigen-specific killer cells New generations for the treatment of solid tumors
Catros, Veronique
M S-MEDECINE SCIENCES, 2019, 35 (04): : 316 - 326

← 1 2 3 4 5 →